[Corrigendum] Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer

• Authors:
  • Xinpeng Li
  • Naxin Yuan
  • Lingdan Lin
  • Lixia Yin
  • Yiqing Qu

• View Affiliations

  
  Affiliations: Department of Respiration, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China, Department of Respiration, Dezhou People's Hospital, Dezhou, Shandong 253014, P.R. China, Department of Cardiology, Dezhou People's Hospital, Dezhou, Shandong 253014, P.R. China
• Published online on: May 11, 2022     https://doi.org/10.3892/etm.2022.11365
• Article Number: 438

• Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

View Figures

Figure 1